J Villumsen
Overview
Explore the profile of J Villumsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen U, Kroyer K, Sander B, Larsen M, Henning V, Villumsen J, et al.
Br J Ophthalmol
. 2008 Nov;
93(8):1005-15.
PMID: 19028741
Aim: To determine the effect of internal limiting membrane (ILM) peeling on anatomical and functional success rates in stage 2 and 3 idiopathic macular hole surgery (MHS). Methods: Randomised clinical...
2.
Stender I, Borgbjerg F, Villumsen J, Lock-Andersen J, Wulf H
Photodermatol Photoimmunol Photomed
. 2006 Nov;
22(6):304-9.
PMID: 17100738
Background: Photodynamic therapy with topical 5-aminolevulinic acid (ALA), followed by irradiation with red light (ALA-PDT), is used for non-melanoma skin cancer and other dermatological diseases. Pain during and after light...
3.
Kjaergard L, Villumsen J, Gluud C
Ann Intern Med
. 2001 Dec;
135(11):982-9.
PMID: 11730399
Purpose: To explore whether reported methodologic quality affects estimated intervention effects in randomized trials and contributes to discrepancies between the results of large randomized trials and small randomized trials in...
4.
Hagg E, Carlberg B, Hillorn V, Villumsen J
Magnes Res
. 1999 Jul;
12(2):123-30.
PMID: 10423707
To test the hypothesis that magnesium depletion might be of importance for the development of vascular complications in diabetes mellitus we performed a randomized, double-blind, placebo-controlled study during 12 months...
5.
Engler C, Sander B, Villumsen J, Lund-Andersen H
Br J Ophthalmol
. 1994 Oct;
78(10):749-53.
PMID: 7528534
The first double masked placebo controlled trial of interferon alfa-2a for the treatment of overt choroidal neovascular membranes is presented. A total of 43 consecutive patients were randomised to double...
6.
Alm A, Villumsen J, Tornquist P, Mandahl A, Airaksinen J, Tuulonen A, et al.
Ophthalmology
. 1993 Sep;
100(9):1312-6; discussion 1316-7.
PMID: 8371917
Purpose: To establish the dose-response relationship for the effect on intraocular pressure (IOP) and side effects during long-term treatment of patients with ocular hypertension with the prostaglandin F2 alpha (PGF2...
7.
Mortensen H, Villumsen J, Volund A, PETERSEN K, Nerup J
Diabet Med
. 1992 Nov;
9(9):834-9.
PMID: 1473324
In 1987 and 1989 nationwide screening for HbA1c was carried out in Denmark. Twenty-one paediatric departments treating children with diabetes participated in the first study and twenty-two in the second....
8.
Villumsen J, Alm A
Br J Ophthalmol
. 1992 Apr;
76(4):214-7.
PMID: 1390487
PhXA34, a prostaglandin analogue, was given topically to 40 patients with untreated ocular hypertension in a double masked randomised study. One single dose of 0.3, 1, 3, 10 micrograms, or...
9.
Alm A, Villumsen J
Arch Ophthalmol
. 1991 Nov;
109(11):1564-8.
PMID: 1755739
The prostaglandin analogue PhXA34 was tested in two studies in normal human eyes; 1, 3, and 10 micrograms of PhXA34 reduced the intraocular pressure by about 2, 3, and 4...
10.